Chronic Migraine Treatment Market 2027 By Treatment, Route of Administration, Distribution Channel | The Insight Partners

Chronic Migraine Treatment Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Treatment (Abortive Treatment, Prophylactic Treatment) ; Route of Administration (Oral, Injectable, Others (Nasal Spray, Transdermal Patch, suppositories)) ; Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Others (Online Pharmacies, Drug Stores))

Report Code: TIPRE00008637 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Chronic migraine is headache occurring on 15 or more days per month for more than three months, which, on at least 8 days per month, has the features of migraine headache. Chronic migraine occurs in approximately 1% of the population.

MARKET DYNAMICS

The chronic migraine treatment market is anticipated to grow in the forecast period due increase in female population and surge in awareness among patients related to prevention and treatment of migraine. However, side effects associated with migraine drugs is a factor is restraining the market growth. Moreover, the presence of growth opportunities in emerging nations is expected to provide new opportunities for the key players in the forecast period.

MARKET SCOPE

The "Chronic Migraine Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in chronic migraine treatment market with detailed market segmentation by treatment, route of administration, distribution channel and geography. The chronic migraine treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in chronic migraine treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The chronic migraine treatment market is segmented on the basis of treatment, route of administration and distribution channel. Based on type the market is segmented as abortive treatment and prophylactic treatment. Further on the basis of abortive treatment the market is categorized as triptans, ergot alkaloids and others. Further on the basis of prophylactic treatment the market is categorized as botulinum toxin, topiramate and others. On the basis of route of administration the market is categorized as oral, injectable and others (nasal spray, transdermal patch, suppositories). On the basis of distribution channel the market is categorized as hospitals pharmacies, retail pharmacies and others (online pharmacies, drug stores).

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in chronic migraine treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chronic migraine treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting chronic migraine treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chronic migraine treatment market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in chronic migraine treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in chronic migraine treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for in chronic migraine treatment market in the global market. Below mentioned is the list of few companies engaged in the chronic migraine treatment market.

The report also includes the profiles of key in chronic migraine treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Alder BioPharmaceutical, Inc.
- Allergan plc.
- AstraZeneca plc.
- Eisai Co., Ltd.
- Eli Lilly & Company
- Endo Pharmaceutical Inc.,
- GlaxoSmithKline plc.
- Janssen Pharmaceutical Company (Johnson & Johnson)
- Merck & Co., Inc.
- Zosano Pharma Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chronic Migraine Treatment Market - By Treatment
1.3.2 Chronic Migraine Treatment Market - By Route of Administration
1.3.3 Chronic Migraine Treatment Market - By Distribution Channel
1.3.4 Chronic Migraine Treatment Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CHRONIC MIGRAINE TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. CHRONIC MIGRAINE TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CHRONIC MIGRAINE TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. CHRONIC MIGRAINE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. CHRONIC MIGRAINE TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. CHRONIC MIGRAINE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. ABORTIVE TREATMENT
7.3.1. Overview
7.3.2. Abortive Treatment Market Forecast and Analysis
7.3.3. Triptans Market
7.3.3.1. Overview
7.3.3.2. Triptans Market Forecast and Analysis
7.3.4. Ergot Alkaloids Market
7.3.4.1. Overview
7.3.4.2. Ergot Alkaloids Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. PROPHYLACTIC TREATMENT
7.4.1. Overview
7.4.2. Prophylactic Treatment Market Forecast and Analysis
7.4.3. Botulinum Toxin Market
7.4.3.1. Overview
7.4.3.2. Botulinum Toxin Market Forecast and Analysis
7.4.4. Topiramate Market
7.4.4.1. Overview
7.4.4.2. Topiramate Market Forecast and Analysis
7.4.5. Others Market
7.4.5.1. Overview
7.4.5.2. Others Market Forecast and Analysis
8. CHRONIC MIGRAINE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INJECTABLE
8.4.1. Overview
8.4.2. Injectable Market Forecast and Analysis
8.5. OTHERS (NASAL SPRAY, TRANSDERMAL PATCH, SUPPOSITORIES)
8.5.1. Overview
8.5.2. Others (Nasal Spray, Transdermal Patch, suppositories) Market Forecast and Analysis
9. CHRONIC MIGRAINE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS PHARMACIES
9.3.1. Overview
9.3.2. Hospitals Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. OTHERS (ONLINE PHARMACIES, DRUG STORES)
9.5.1. Overview
9.5.2. Others (Online Pharmacies, Drug Stores) Market Forecast and Analysis
10. CHRONIC MIGRAINE TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Chronic Migraine Treatment Market Overview
10.1.2 North America Chronic Migraine Treatment Market Forecasts and Analysis
10.1.3 North America Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.1.4 North America Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Chronic Migraine Treatment Market
10.1.6.1.1 United States Chronic Migraine Treatment Market by Treatment
10.1.6.1.2 United States Chronic Migraine Treatment Market by Route of Administration
10.1.6.1.3 United States Chronic Migraine Treatment Market by Distribution Channel
10.1.6.2 Canada Chronic Migraine Treatment Market
10.1.6.2.1 Canada Chronic Migraine Treatment Market by Treatment
10.1.6.2.2 Canada Chronic Migraine Treatment Market by Route of Administration
10.1.6.2.3 Canada Chronic Migraine Treatment Market by Distribution Channel
10.1.6.3 Mexico Chronic Migraine Treatment Market
10.1.6.3.1 Mexico Chronic Migraine Treatment Market by Treatment
10.1.6.3.2 Mexico Chronic Migraine Treatment Market by Route of Administration
10.1.6.3.3 Mexico Chronic Migraine Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Chronic Migraine Treatment Market Overview
10.2.2 Europe Chronic Migraine Treatment Market Forecasts and Analysis
10.2.3 Europe Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.2.4 Europe Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Chronic Migraine Treatment Market
10.2.6.1.1 Germany Chronic Migraine Treatment Market by Treatment
10.2.6.1.2 Germany Chronic Migraine Treatment Market by Route of Administration
10.2.6.1.3 Germany Chronic Migraine Treatment Market by Distribution Channel
10.2.6.2 France Chronic Migraine Treatment Market
10.2.6.2.1 France Chronic Migraine Treatment Market by Treatment
10.2.6.2.2 France Chronic Migraine Treatment Market by Route of Administration
10.2.6.2.3 France Chronic Migraine Treatment Market by Distribution Channel
10.2.6.3 Italy Chronic Migraine Treatment Market
10.2.6.3.1 Italy Chronic Migraine Treatment Market by Treatment
10.2.6.3.2 Italy Chronic Migraine Treatment Market by Route of Administration
10.2.6.3.3 Italy Chronic Migraine Treatment Market by Distribution Channel
10.2.6.4 Spain Chronic Migraine Treatment Market
10.2.6.4.1 Spain Chronic Migraine Treatment Market by Treatment
10.2.6.4.2 Spain Chronic Migraine Treatment Market by Route of Administration
10.2.6.4.3 Spain Chronic Migraine Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Chronic Migraine Treatment Market
10.2.6.5.1 United Kingdom Chronic Migraine Treatment Market by Treatment
10.2.6.5.2 United Kingdom Chronic Migraine Treatment Market by Route of Administration
10.2.6.5.3 United Kingdom Chronic Migraine Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Chronic Migraine Treatment Market Overview
10.3.2 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.3.4 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Chronic Migraine Treatment Market
10.3.6.1.1 Australia Chronic Migraine Treatment Market by Treatment
10.3.6.1.2 Australia Chronic Migraine Treatment Market by Route of Administration
10.3.6.1.3 Australia Chronic Migraine Treatment Market by Distribution Channel
10.3.6.2 China Chronic Migraine Treatment Market
10.3.6.2.1 China Chronic Migraine Treatment Market by Treatment
10.3.6.2.2 China Chronic Migraine Treatment Market by Route of Administration
10.3.6.2.3 China Chronic Migraine Treatment Market by Distribution Channel
10.3.6.3 India Chronic Migraine Treatment Market
10.3.6.3.1 India Chronic Migraine Treatment Market by Treatment
10.3.6.3.2 India Chronic Migraine Treatment Market by Route of Administration
10.3.6.3.3 India Chronic Migraine Treatment Market by Distribution Channel
10.3.6.4 Japan Chronic Migraine Treatment Market
10.3.6.4.1 Japan Chronic Migraine Treatment Market by Treatment
10.3.6.4.2 Japan Chronic Migraine Treatment Market by Route of Administration
10.3.6.4.3 Japan Chronic Migraine Treatment Market by Distribution Channel
10.3.6.5 South Korea Chronic Migraine Treatment Market
10.3.6.5.1 South Korea Chronic Migraine Treatment Market by Treatment
10.3.6.5.2 South Korea Chronic Migraine Treatment Market by Route of Administration
10.3.6.5.3 South Korea Chronic Migraine Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Chronic Migraine Treatment Market Overview
10.4.2 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.4.4 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Chronic Migraine Treatment Market
10.4.6.1.1 South Africa Chronic Migraine Treatment Market by Treatment
10.4.6.1.2 South Africa Chronic Migraine Treatment Market by Route of Administration
10.4.6.1.3 South Africa Chronic Migraine Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Chronic Migraine Treatment Market
10.4.6.2.1 Saudi Arabia Chronic Migraine Treatment Market by Treatment
10.4.6.2.2 Saudi Arabia Chronic Migraine Treatment Market by Route of Administration
10.4.6.2.3 Saudi Arabia Chronic Migraine Treatment Market by Distribution Channel
10.4.6.3 U.A.E Chronic Migraine Treatment Market
10.4.6.3.1 U.A.E Chronic Migraine Treatment Market by Treatment
10.4.6.3.2 U.A.E Chronic Migraine Treatment Market by Route of Administration
10.4.6.3.3 U.A.E Chronic Migraine Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Chronic Migraine Treatment Market Overview
10.5.2 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis
10.5.3 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis - By Treatment
10.5.4 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Chronic Migraine Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Chronic Migraine Treatment Market
10.5.6.1.1 Brazil Chronic Migraine Treatment Market by Treatment
10.5.6.1.2 Brazil Chronic Migraine Treatment Market by Route of Administration
10.5.6.1.3 Brazil Chronic Migraine Treatment Market by Distribution Channel
10.5.6.2 Argentina Chronic Migraine Treatment Market
10.5.6.2.1 Argentina Chronic Migraine Treatment Market by Treatment
10.5.6.2.2 Argentina Chronic Migraine Treatment Market by Route of Administration
10.5.6.2.3 Argentina Chronic Migraine Treatment Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CHRONIC MIGRAINE TREATMENT MARKET, KEY COMPANY PROFILES
12.1. ALDER BIOPHARMACEUTICAL, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTRAZENECA PLC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EISAI CO., LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ENDO PHARMACEUTICAL INC.,
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JANSSEN PHARMACEUTICAL COMPANY (JOHNSON AND JOHNSON)
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERCK AND CO., INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ZOSANO PHARMA CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Alder BioPharmaceutical, Inc.
2. Allergan plc.
3. AstraZeneca plc.
4. Eisai Co., Ltd.
5. Eli Lilly and Company
6. Endo Pharmaceutical Inc.,
7. GlaxoSmithKline plc.
8. Janssen Pharmaceutical Company (Johnson and Johnson)
9. Merck and Co., Inc.
10. Zosano Pharma Corporation
TIPRE00008637
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking